Terminating CHAVD is part of broader Trump administration cuts to HIV vaccine research. In an emailed statement Tuesday, an HHS spokesperson said the agency has been supporting “duplicative ...

Terminating CHAVD is part of broader Trump administration cuts to HIV vaccine research. In an emailed statement Tuesday, an HHS spokesperson said the agency has been supporting "duplicative health ...

The Trump administration terminated $258 million in funding to the Center for HIV/AIDS Vaccine Development (CHAVD) Friday, including $129 million for Duke.. Researchers were told that the ...

The current presidential administration has ended funding for the Center for HIV/AIDS Vaccine Development (CHAVD), a move that researchers say will likely set efforts to end HIV globally back by a ...

The Trump administration's termination of CHAVD is just the latest in a string of cuts and cancellations of HIV-vaccine related grants, from clinical trials to basic laboratory research.

After decades of failing to develop an effective vaccine against HIV, the federal government has committed $129 million to a new effort led by Scripps Research.The National Institutes of Health ...

Among their HIV discoveries, the CHAVD team has identified the mechanisms the AIDS virus uses to infect humans, and they have developed effective strategies to outmaneuver the virus's stealth.

The Scripps Consortium for HIV/AIDS Vaccine Development (CHAVD), an international collaboration led by Scripps Research, has received a $129 million grant from the National Institutes of Health to ...

Thanks to a $129 million federal grant, the Duke Human Vaccine Institute (DHVI) will continue its now 14-year long effort to develop a vaccine for HIV.

An international partnership led by Scripps Research on July 10 pulled in a $129 million grant to bring a potential HIV vaccination into clinical testing.

Terminating CHAVD is part of broader Trump administration cuts to HIV vaccine research. In an emailed statement Tuesday, an HHS spokesperson said the agency has been supporting “duplicative ...